Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-05-16
2008-10-07
Belyavskyi, Michail A (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
07432065
ABSTRACT:
The invention provides reagents and methods for inhibiting or enhancing interactions between proteins in hematopoietic cells and other cells involved in the mediation of an immune response. Reagents and methods provided are useful for treatment of a variety of diseases and conditions mediated by immune system cells.
REFERENCES:
patent: 5632994 (1997-05-01), Reed et al.
patent: 5652210 (1997-07-01), Barr et al.
patent: 5674734 (1997-10-01), Leder et al.
patent: 5747245 (1998-05-01), Reed et al.
patent: 5863898 (1999-01-01), Goli et al.
patent: 5876939 (1999-03-01), Reed et al.
patent: 5958731 (1999-09-01), Yue et al.
patent: 5976819 (1999-11-01), Finkel et al.
patent: 6174702 (2001-01-01), Lal et al.
patent: 6306395 (2001-10-01), Nakamura et al.
patent: 6911526 (2005-06-01), Sato et al.
patent: 6942981 (2005-09-01), Lu et al.
patent: 2002/0058607 (2002-05-01), Sato et al.
patent: 2002/0147306 (2002-10-01), Lin et al.
patent: 2003/0049695 (2003-03-01), Lu et al.
patent: 2003/0050243 (2003-03-01), Tymianski
patent: 2003/0203414 (2003-10-01), Sato et al.
patent: 2004/0018487 (2004-01-01), Lu et al.
patent: 2004/0229298 (2004-11-01), Lu et al.
patent: 2005/0019841 (2005-01-01), Garman et al.
patent: 2005/0037969 (2005-02-01), Lu et al.
patent: 2005/0059597 (2005-03-01), Tymianski et al.
patent: 2005/0214869 (2005-09-01), Lu et al.
patent: 2005/0221388 (2005-10-01), Lu et al.
patent: 2005/0255460 (2005-11-01), Lu et al.
patent: 2005/0282743 (2005-12-01), Lu et al.
patent: 2006/0148711 (2006-07-01), Lu et al.
patent: 2007/0099199 (2007-05-01), Lu et al.
patent: 2007/0128699 (2007-06-01), Lu et al.
patent: 2273622 (2000-12-01), None
patent: WO 98/05347 (1998-02-01), None
patent: WO 9823781 (1998-04-01), None
patent: WO 98/23781 (1998-06-01), None
patent: WO 98/40407 (1998-09-01), None
patent: WO 99/03974 (1999-01-01), None
patent: WO 99/07846 (1999-02-01), None
patent: WO 00/15794 (2000-03-01), None
patent: WO 00/31124 (2000-06-01), None
patent: WO 00/48002 (2000-08-01), None
patent: WO 00/69896 (2000-11-01), None
patent: WO 00/69897 (2000-11-01), None
patent: WO 00/69898 (2000-11-01), None
patent: WO 02/31512 (2002-04-01), None
patent: WO 02/42422 (2002-05-01), None
patent: WO 03/014303 (2003-02-01), None
patent: WO 2004/022006 (2004-03-01), None
patent: WO 2004/045535 (2004-06-01), None
patent: WO 2004/076646 (2004-09-01), None
Altin, J. and Sloan, E. “The role of CD45 and CD45-associated molecules in T cell activation”Immunology and Cell Biology, 1997, pp. 430-445, vol. 75.
Bals, R. et al. “Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide”,Infection and Immunity, Nov. 1999, pp. 6084-6089, vol. 67, No. 11.
Barclay, A., et al., “The Leukocyte Antigen Factsbook”,Harcourt Braces&Company, p. 363, (1997).
Brenman et al. “Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains.” Cell, 1996, pp. 757-767, vol. 84, No. 5.
Bruyns, E. et al. “Identification of the Sites of Interaction between Lyphocyte Phosphatase-associated Phophoprotein (LPAP) and CD45”,Journal of Biological Chemistry, Dec. 29, 1996, pp. 31372-31376, vol. 270, No. 52, U.S.A.
Burgess, Wilson H. et al. “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue” Journal of Cell Biology, Nov. 1990, pp. 2129-2138, vol. 111, The Rockefeller University Press.
Cherukuri, A. et al. “Floating the raft hypothesis: lipid rafts play a role in immune cell activation”,Immunity, Jun. 2001, pp. 657-660, vol. 14, Cell Press.
Coligan et al. eds.,Current Protocols In Immunology, pp. 2.03-2.1.9 (1991).
Ding, I. Et al., “Biochemical and Functional Analysis of Mice Deficient in Expression of the CD45-Associated Phosphoprotein LPAP”,European Journal of Immunology, 29(12):3956-61 (1999).
Doyle, D. A., et al., “Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ”,Cell, 85(7):1067-76, (1996).
Fabre, Stéphane et al. “Identification of functional PDZ domain binding sites in several human proteins” Molecular Biology Reports, 2000, pp. 217-224, vol. 27, No. 4.
Faulkner, G. et al. “A New Z-band Alternatively Spliced PDZ-motif Protein.”The Journal of Cell Biology, Jul. 26, 1999; pp. 465-475, vol. 146, No. 2.
Fukui, Yoshinori et al. “Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration”Nature, Aug. 23, 2001, pp. 826-831, vol. 412.
Gardiol, D. et al. “Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation”,Oncogene, 18(40):5487-5496, (1999).
Gee et al., “Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins,”J. Neurosci., 18(1):128-137 (1998).
Gee., S.H., et al., “Cyclic Peptides as Non-carboxyl-terminal Ligands of Syntrophin PDZ Domains”,The Journal of Biological Chemistry, 273(34):21980-21987, (1998).
GenBank, Accession No. AF028823, Dec. 1, 1999.
GenBank, Accession No. BM845132, Mar. 6, 2002.
GenBank, Accession No. CB131761, Jan. 29, 2003.
GenBank, Accession No. CB961389, Apr. 28, 2003.
GenBank, Accession No. CB995033, Apr. 30, 2003.
Genbank, Accession No. D86964, Feb. 7, 1999.
Hanada, T., et al., “Human Homologue of theDrosophilaDiscs Larger Tumor Suppressor Binds to p56IckTyrosine Kinase and Shaker Type Kvl.3 Potassium Channel in T. Lymphocytes”,The Journal of Biological Chemistry, 272(43):26899-26904, (1997).
Kiyono, T. et al. “Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of theDrosophiladiscs large tumor suppressor protein”,Proc. Natl. Acad. Sci., Oct. 1997, pp. 11612-11616, vol. 94, U.S.A.
Kobayashi, I., et al., “Identification of an Autoimmune Enteropathy-related 75-kilodalton Antigen”,Gastroenterology, Oct. 1999, pp. 823-830, vol. 117, No. 4.
Kornau et al. “Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95.” Science, 1995, pp. 1737-1740, vol. 269, No. 5231.
Lazar, Eliane et al. “Transforming Growth Factor γ: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities” Molecular and Cellular Biology, Mar. 1988, pp. 1247-1252, vol. 8, No. 3.
Lee, Siu Sylvia et al. “Binding of human virus oncoproteins to hDIg/SAP97, a mammalian homolog of theDrosophiadiscs large tumor suppressor protein” Proceedings of the Nat. Acad. Of Sci. USA, Jun. 1997, pp. 6670-6675, vol. 94.
Maekawa, K., et al., “Association of Protein-Tyrosine Phosphatasee PTP-BAS with the Transcription-factor-inhibitory Protein IκBα Through Interaction Between the PDZI Domain and Ankyrin Repeats”,Biochemical Journal, 337(2):179-187, (1999).
Marfatia, Shirin et al. “The PDZ domain of human erythrocyte p55 mediates its binding to the cytoplasmic carboxy terminus of Glycophorin C” The Journal of Biological Chemistry, Sep. 1997, pp. 24191-24197, vol. 272, No. 39.
McKusick, Victor A.; OMIM Database entry entitled, ′147138 Fc Fragment of IgE, High Affinity I, Receptor for, Beta Subunit; FCER1B′, www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?147138, Aug. 27, 1992.
Mikayama, Toshifumi et al. “Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor” Proc. Natl. Acad. Sci., Nov. 1993, pp. 10056-10060, vol. 90.
Nagase, T. et al. “Prediction of the Coding Sequence of Unidentified Human Genes. VI. The Coding Sequences of 80 New Genes (KIAA0201-KIAA0280) Deduced by Analysis of cDNA Clones from Cell Line KG-1 and Brain”,DNA Research, 1996, pp. 321-329, vol. 3.
N
Lu Peter S.
Rabinowitz Joshua D.
Schweizer Johannes
Arbor Vita Corporation
Belyavskyi Michail A
Townsend and Townsend / and Crew LLP
LandOfFree
Methods of identifying modulators of interaction between PDZ... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of identifying modulators of interaction between PDZ..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying modulators of interaction between PDZ... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3993848